Related Experiment Videos
Elevations in thyroid-stimulating hormone in normal subjects after receiving short-term lithium carbonate
M V Nelson1, V Tutag-Lehr, R L Evans
1College of Pharmacy and Allied Health, Wayne State University, Detroit, MI.
Drug Intelligence & Clinical Pharmacy
|March 1, 1988
Summary
Short-term lithium carbonate use in healthy males significantly increased thyroid-stimulating hormone (TSH) levels. Baseline TSH predicted the rise, but lithium levels did not, suggesting early monitoring is crucial for thyroid function during lithium therapy.
Area of Science:
- Endocrinology
- Pharmacology
- Internal Medicine
Background:
- Lithium carbonate is a common treatment for bipolar disorder.
- Thyroid dysfunction is a known potential side effect of long-term lithium therapy.
- The early effects of lithium on thyroid function require further elucidation.
Purpose of the Study:
- To investigate the acute effects of oral lithium carbonate on thyroid-stimulating hormone (TSH) levels in healthy male subjects.
- To determine if baseline TSH concentrations or lithium serum levels correlate with TSH changes during short-term treatment.
Main Methods:
- Nine healthy male subjects received oral lithium carbonate for two weeks.
- Thyroid-stimulating hormone (TSH) concentrations were measured at baseline and after 15 days.
- Lithium serum concentrations were monitored.
Main Results:
- A significant elevation in TSH concentrations was observed after 15 days of lithium carbonate administration.
- TSH levels after 15 days were significantly correlated with baseline TSH concentrations.
- No significant correlation was found between lithium serum concentration and TSH levels after 15 days.
Conclusions:
- Short-term lithium carbonate use can acutely increase TSH levels in healthy individuals.
- Baseline TSH may be a predictor of TSH response to lithium.
- Further research is needed to identify predictors of hypothyroidism in patients on long-term lithium therapy.